Table 2.
Relationship between SBF2-AS1 and clinicopathological features of OS patients.
| Clinicopathological data | Sample number n | SBF2-AS1 expression | P |
|---|---|---|---|
| Age (years) | 0.179 | ||
| <25 | 25 | 2.80 ± 0.23 | |
| ≥25 | 20 | 2.69 ± 0.31 | |
| Gender | 0.566 | ||
| Female | 35 | 3.01 ± 0.13 | |
| Male | 10 | 2.98 .90.19 | |
| Tumor size | <0.001 | ||
| <5 cm | 27 | 1.75 ± 0.27 | |
| ≥5 cm | 18 | 2.79 ± 0.15 | |
| Tumor location | 0.678 | ||
| Tibia | 16 | 2.78 ± 0.14 | |
| Femur | 19 | 2.75 ± 0.17 | |
| Others | 10 | 2.82 ± 0.32 | |
| Enneking stage | <0.001 | ||
| I | 21 | 1.48 ± 0.16 | |
| II | 15 | 1.89 ± 0.24 | |
| III | 9 | 2.65 ± 0.18 | |
| Distant metastasis | <0.001 | ||
| Yes | 19 | 2.69 ± 0.18 | |
| No | 26 | 1.57 ± 0.20 |
The data in the table were all measurement data expressed as mean ± standard deviation, and comparison between two groups was analyzed by independent sample t test.